Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,409-9,420 of 23,847
Drug study icon
CompletedNCT00835107

An Investigation of Sleep Architecture in Ziprasidone-Treated Depression in bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve sleep, daily rhythms, and longer-term stability.

In Kingston
Bipolarity, DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
Canada
Sponsor
Queen's University
Condition
Bipolarity, Depression
Behavioral study icon
Enrolling By InvitationNCT07220330

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

This observational study is following people with No History of ADHD or Attention Deficit Hyperactivity Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including San Jose
ADHDBehavioralFrom 6 Years to 60 Years
Countries
United States
Sponsor
Qbtech AB
Condition
ADHD
Other study type icon
Enrolling By InvitationNCT07217977

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

This observational study is following people with Attention Deficit Disorder With Hyperactivity or Attention Deficit Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Mobile
ADHDOtherFrom 6 Years to 60 Years
Countries
United States
Sponsor
Qbtech AB
Condition
ADHD
Drug study icon
CompletedNCT00192023

Efficacy of Atomoxetine for ADHD

This study is completed in Italy. It is testing efficacy of Atomoxetine for ADHD.

Multiple locations, including Alessandria
ADHDDrugFrom 6 Years to 15 Years
Countries
Italy
Sponsor
Eli Lilly and Company
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.